Symphony Financial’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-4,970
Closed -$352K 198
2023
Q3
$352K Sell
4,970
-223
-4% -$16.7K 0.09% 120
2023
Q2
$398K Sell
5,193
-1,089
-17% -$84.3K 0.1% 134
2023
Q1
$473K Buy
6,282
+1,114
+22% +$82.8K 0.12% 145
2022
Q4
$412K Sell
5,168
-14,575
-74% -$1.09M 0.11% 153
2022
Q3
$1.42M Buy
19,743
+797
+4% +$62.5K 0.46% 53
2022
Q2
$1.51M Sell
18,946
-374
-2% -$29.2K 0.45% 47
2022
Q1
$1.55M Buy
19,320
+6,816
+55% +$540K 0.37% 57
2021
Q4
$1.06M Sell
12,504
-10,288
-45% -$803K 0.29% 68
2021
Q3
$1.76M Sell
22,792
-267
-1% -$21.2K 0.61% 38
2021
Q2
$1.87M Sell
23,059
-347
-1% -$28.4K 0.64% 37
2021
Q1
$1.87M Buy
+23,406
New +$1.83M 0.49% 40

Other funds holding CL

Symphony Financial's CL Position: Q4 2023 in Review

Symphony Financial sold out of Colgate-Palmolive (CL) in Q4 2023, closing a stake of 4,970 shares — an estimated $352K sold.

Symphony Financial first reported a position in CL in Q1 2021 and held it in 11 quarters. The position peaked at $1.87M in Q2 2021. 1,740 funds tracked by Wall St. Rank hold CL as of Q4 2023.

  • Symphony Financial reported no remaining Colgate-Palmolive position as of Q4 2023 after selling out during the quarter.
  • Symphony Financial sold 4,970 Colgate-Palmolive shares in Q4 2023, an estimated $352K.
  • Symphony Financial first reported a position in Colgate-Palmolive in Q1 2021 and held it in 11 quarters.
  • Symphony Financial's Colgate-Palmolive position peaked at $1.87M in Q2 2021.
  • 1,740 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q4 2023.

Based on Symphony Financial's 13F filing for Q4 2023, filed 18 Jan 2024.